60PD Inhibition of pEGFR in paired tumour biopsies from TKI treatment-naïve EGFR mutant NSCLC patients treated with gefitinib (EGFR inhibitor) or gefitinib in combination with durvalumab (anti-PD-L1).

Journal Article

Full Text

Duke Authors

Cited Authors

  • Yeh, T; Jacobs, V; Angell, H; Geradts, J; Hou, J; Karakunnel, J; Barrett, C

Published Date

  • April 2016

Published In

Volume / Issue

  • 11 / 4 Suppl

Start / End Page

  • S80 - S81

PubMed ID

  • 27198416

Pubmed Central ID

  • 27198416

Electronic International Standard Serial Number (EISSN)

  • 1556-1380

Digital Object Identifier (DOI)

  • 10.1016/S1556-0864(16)30173-3

Language

  • eng

Conference Location

  • United States